3,640 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Symmetry Investments LP

Symmetry Investments LP bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,640 shares of the company’s stock, valued at approximately $1,169,000.

Several other large investors have also bought and sold shares of HCA. Gladstone Institutional Advisory LLC acquired a new stake in HCA Healthcare during the 4th quarter worth about $200,000. Corient Private Wealth LLC grew its holdings in HCA Healthcare by 22.8% during the 4th quarter. Corient Private Wealth LLC now owns 43,140 shares of the company’s stock worth $11,677,000 after acquiring an additional 8,005 shares during the period. Assetmark Inc. grew its holdings in HCA Healthcare by 27.6% during the 4th quarter. Assetmark Inc. now owns 1,495 shares of the company’s stock worth $405,000 after acquiring an additional 323 shares during the period. Commerce Bank grew its stake in shares of HCA Healthcare by 31.9% in the 4th quarter. Commerce Bank now owns 11,007 shares of the company’s stock valued at $2,979,000 after buying an additional 2,660 shares during the period. Finally, FineMark National Bank & Trust acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at about $973,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 0.2 %

NYSE:HCA opened at $404.37 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market capitalization of $105.91 billion, a PE ratio of 20.16, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. The firm’s 50 day moving average is $370.57 and its 200 day moving average is $340.59. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $405.70.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter in the previous year, the firm posted $4.29 EPS. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. Sell-side analysts expect that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.65%. HCA Healthcare’s payout ratio is 13.16%.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft raised their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Royal Bank of Canada raised their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Monday, August 19th. Finally, Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $359.89.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock valued at $6,407,273 in the last 90 days. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.